WHO/Q. Mattingly
© Credits

Antimicrobial resistance

    Overview

    Antimicrobial resistance (AMR) threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi.

    AMR occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines making infections harder to treat and increasing the risk of disease spread, severe illness and death. As a result, the medicines become ineffective and infections persist in the body, increasing the risk of spread to others.

    Antimicrobials - including antibiotics, antivirals, antifungals and antiparasitics - are medicines used to prevent and treat infections in humans, animals and plants. Microorganisms that develop antimicrobial resistance are sometimes referred to as “superbugs”.

    News

    All →

    WHO AWaRe antibiotic book feedback survey report

    Oct 1, 2025, 11:41 AM

    The 2022 WHO AWaRe (Access, Watch, Reserve) antibiotic book is used to support antibiotic stewardship efforts globally. An online survey was used to obtain feedback on its content, format and suggestions for future updates. The survey was available in English, Spanish and French and open between 15 July to 15 September 2024.

    A total of 301 responses were received, of which 81% (n=244) were from low- and middle-income countries (LMICs). The majority (n=282, 94%) of responses were recorded in English and approximately half (157/301, 52%) were health-care workers. Respondents indicated a reliance on multiple resources and guidelines for clinical decision support.

    Clarity and format were generally well received with no major issues identified. Respondents expressed interest in making the book available in different formats and employing various methods such as colour coding and indexing to improve useability.

    According to respondents, the most important topics to consider for addition to the book include targeted therapy for infections caused by Staphylococcus aureus (97%, 273/281), Escherichia coli (97%, 269/278) and Klebsiella pneumoniae (96%, 268/278), clinical management of surgical site infections (96%, 286/297) and healthcare-associated infections such as catheter-related bloodstream infections (95%, 265/279) and catheter-associated urinary tract infections (95%, 267/282).

    The high ranking of most suggested additional content complicates the prioritization of new topics; however, this also indicates that these updates would be well-received. Updates to the book will be prioritised and completed based on the availability of resources. 

    Read more in the:

    Latest publications

    All →
    Antimicrobial resistance and infection prevention and control curriculum assessment tool for nursing and midwifery education

    Antimicrobial resistance (AMR) poses a major threat to global health, patient safety and health system resilience. Poor infection prevention and control...

    Antimicrobial resistance curriculum assessment tool for pharmacy education

    The Global Action Plan on Antimicrobial Resistance (AMR) calls for making AMR a core component of professional education and training. In 2018, the World...

    Target product profiles for new antibacterial agents

    This World Health Organization (WHO) report presents target product profiles (TPPs) for new antibacterial agents for therapy of severe infections caused...

    Mainstreaming antimicrobial resistance into primary health care: international workshop report

    The Asia-Europe Foundation (ASEF) and the World Health Organization (WHO) organized an international workshop from 18 to 20 March 2025 in Bangkok, Thailand,...

    Our work

    Documents

    All →

    Country profiles

    Country profiles

    Country profiles present selected data, statistics and information to provide national health profiles at given points in time.
    GO